Davita price to free cash flow DVA

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026: 7.3×
10-year median: 8.7×
Against its 10-year history: 24th; percentile: 0 is its lowest day, 100 its highest
10-year range: 4.9× to 26.6×
Peer median: 22.6×

Davita's price to free cash flow is 7.3× as of Oct 23, 2026.

That is below its ten-year median of 8.7×, lower than on 76% of days in the last ten years.

Over that time it ranged from 4.9× in Oct 2023 to 26.6× in Jun 2018.

The median for 10 hospital and care facility stocks of a similar size is 22.6×.

Price to free cash flow over time

median 8.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	7.3×	5.7×	10.3×
2025	6.2×	5.8×	10.2×
2024	8.9×	7.2×	14.0×
2023	7.3×	4.9×	8.7×
2022	5.8×	5.0×	9.8×
2021	9.6×	7.8×	12.4×
2020	8.7×	5.9×	11.7×
2019	10.2×	9.5×	16.6×
2018	11.1×	11.0×	26.6×
2017	11.5×	8.2×	12.4×
2016	11.6×	8.9×	36.6×
2015	37.7×	12.9×	41.8×
2014	13.4×	12.2×	14.8×
2013	12.9×	11.4×	24.3×
2012	20.0×	9.2×	20.6×
2011	8.9×	8.6×	15.0×
2010	10.7×	10.2×	12.6×

Against its peers

Companies in Medical - Care Facilities nearest Davita's size, closest first, today.

Company	Price to free cash flow
DVADavita	7.3×
BTSGBrightSpring Health Services	29.6×
EHCEncompass Health	29.6×
UHSUniversal Health Services	13.0×
ENSGEnsign	24.4×
PACSPACS	16.6×
CHEChemed	20.7×
THCTenet Healthcare	7.2×
SHCSotera Health	45.8×
CONConcentra Group Holdings Parent	18.7×
LFSTLifeStance Health	28.4×
Peer median	22.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Davita

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.